Iboga Powder/Pure Iboga Powder for sale
Iboga Powder/Pure Iboga Powder for sale is a naturally occurring psychoactive substance found in plants in the family Apocynaceae such as Tabernanthe iboga, Voacanga africana, and Tabernaemontana undulata. It is a psychedelic with dissociative properties.
Preliminary research indicates that it may help counter drug addiction. Its use has been associated with serious side effects and death. Between the years 1990 and 2008, a total of 19 fatalities temporally associated with the ingestion of ibogaine were reported, from which six subjects died of acute heart failure or cardiopulmonary arrest.
The total number of subjects who have used it without major side effects during this period remains unknown.
It is used as an alternative medicine treatment for drug addiction in some countries. Its prohibition in other countries has slowed scientific research. Ibogaine is also used to facilitate psychological introspection and spiritual exploration.
Derivatives of ibogaine that lack the substance’s psychedelic properties (such as 18-MC) are under clinical trials, have been shown to be neither psychedelic nor psychoactive, and have a positive safety profile in humans.
Iboga Powder/Pure Iboga Powder for saleThe psychoactivity of the root barks of the iboga tree (Tabernanthe iboga), from which ibogaine is extracted, was first discovered by the Pygmy tribes of Central Africa, who passed the knowledge to the Bwiti tribe of Gabon. French explorers in turn learned of it from the Bwiti tribe and brought iboga back to Europe in 1899–1900, where it was subsequently marketed in France as Lambarene.
Ibogaine-containing preparations are used for medicinal and ritual purposes within African spiritual traditions of the Bwiti, who claim to have learned it from the Pygmy peoples. Although it was first commonly advertised as having anti-addictive properties in 1962 by Howard Lotsof, its Western use predates that by at least a century. In France, it was marketed as Lambarène and used as a stimulant.
Also, the U.S. Central Intelligence Agency (CIA) studied the effects of ibogaine in the 1950s.. Iboga Powder/Pure Iboga Powder for saleIboga Powder/Pure Iboga Powder for sale is an indole alkaloid that is obtained either by extraction from the iboga plant or by semi-synthesis from the precursor compound voacangine, another plant alkaloid. The total synthesis of ibogaine was described in 1956. Structural elucidation by X-ray crystallography was completed in 1960.
Psychoactive effects of Iboga Powder/Pure Iboga Powder for sale
Ibogaine is derived from the root of the Tabernanthe iboga, a plant known to exhibit psychedelic effects in its users. The experience of ibogaine occurs in two phases, termed the visionary phase and the introspection phase.
The visionary phase has been described as oneirogenic, referring to the dreamlike nature of its psychedelic effects, and lasts for 4 to 6 hours. The second phase, the introspection phase, is responsible for the psychotherapeutic effects.
It can allow people to conquer their fears and negative emotions. Ibogaine catalyzes an altered state of consciousness reminiscent of dreaming while fully conscious and aware so that memories, life experiences, and issues of trauma can be processed .
Medical Uses Of Iboga Powder/Pure Iboga Powder for sale
See also: Ibogaine § Research
Ibogaine is not currently approved for any medical uses. There are legal ibogaine rehabilitation facilities in Mexico. Clinical studies of ibogaine to treat drug addiction began in the early 1990s, but concerns about cardiotoxicity led to termination of those studies. There is currently insufficient data to determine whether it is useful in treating addiction.
Nonetheless, some alternative medicine clinics administer ibogaine for this purpose, in what has been called a “vast, uncontrolled experiment.” As of May 2020, there is a phase-2 clinical trial of ibogaine for the treatment of alcoholism scheduled for August 2020 in Brazil.
In Bwiti religious ceremonies, the root bark is pulverized and swallowed in large amounts to produce intense psychoactive effects. Iboga Powder/Pure Iboga Powder for sale
Adverse effects of Iboga Powder/Pure Iboga Powder for sale
One of the first noticeable effects of large-dose ibogaine ingestion is ataxia, a difficulty in coordinating muscle motion which makes standing and walking difficult without assistance. Xerostomia (dry mouth), nausea, and vomiting may follow.
These symptoms may be long in duration, ranging from 4 to 24 hours in some cases. Ibogaine is sometimes administered per rectum to avoid nausea and vomiting. Ibogaine decreases body temperature.
Ibogaine causes long QT syndrome at higher doses, apparently by blocking hERG potassium channels in the heart.]
Work in the laboratory of Mark Molliver at Johns Hopkins indicated degeneration of cerebellar Purkinje cells observed in rats given substantially larger dosages of ibogaine than those used to study drug self-administration and withdrawal. However, subsequent research found no evidence of neurotoxicity in a primate or mouse at dosages that produced cerebellar degeneration in the rat, and it has been suggested that cerebellar degeneration might be a phenomenon limited to a single species.
The FDA was aware of Molliver’s work at the time it approved a phase-1 study in which humans received ibogaine in 1993. Neuropathological examination revealed no evidence of degenerative changes in a woman who had received four separate doses of ibogaine ranging between 10 and 30 mg⁄ kg over a 15-month interval.
A published series of fatalities temporally associated with the ingestion of ibogaine found no evidence suggesting a characteristic syndrome of neurotoxicity. Iboga Powder/Pure Iboga Powder for sale
The most-studied therapeutic effect of ibogaine is the reduction or elimination of addiction to opioids. An integral effect is the alleviation of symptoms of opioid withdrawal. Research also suggests that ibogaine may be useful in treating dependence on other substances such as alcohol, methamphetamine, and nicotine, and may affect compulsive behavioral patterns not involving substance abuse or chemical dependence. Researchers note that there remains a “need for systematic investigation in a conventional clinical research setting.” Iboga Powder/Pure Iboga Powder for sale
Many users of ibogaine report experiencing visual phenomena during a waking dream state, such as instructive replays of life events that led to their addiction, while others report therapeutic shamanic visions that help them conquer the fears and negative emotions that might drive their addiction.
It is proposed that intensive counseling, therapy, and aftercare during the interruption period following treatment is of significant value. Some individuals require a second or third treatment session with ibogaine over the course of 12 to 18 months. A minority of individuals relapse completely into opiate addiction within days or weeks.
A comprehensive article (Lots of 1995) on the subject of ibogaine therapy detailing the procedure, effects, and aftereffects is found in “Ibogaine in the Treatment of Chemical Dependence Disorders: Clinical Perspectives”. Ibogaine has also been reported in multiple small-study cohorts to reduce cravings for methamphetamine. Iboga Powder/Pure Iboga Powder for sale
There is also evidence that this type of treatment works with LSD, which has been shown to have a therapeutic effect on alcoholism. Both ibogaine and LSD appear to be effective for encouraging introspection and giving the user occasion to reflect on the sources of their addiction, while also producing an intense, transformative experience that can put established patterns of behavior into perspective; ibogaine has the added benefit of preventing withdrawal effects.
Chronic pain management
In 1957, Jurg Schneider, a pharmacologist at CIBA (now a division of Novartis), found that ibogaine potentiated morphine analgesia. No additional data was ever published by CIBA researchers on ibogaine–opioid interactions. Almost 50 years later, Patrick Kroupa and Hattie Wells released the first treatment protocol for concomitant administration of ibogaine with opioids in human subjects, indicating that ibogaine reduced tolerance to opioid drugs.
Their paper in the Multidisciplinary Association for Psychedelic Studies journal demonstrated that administration of low “maintenance” doses of ibogaine HCl with opioids decreases tolerance, but noted that ibogaine’s potentiating action could make this a risky procedure.
Ibogaine has been used as an adjunct to psychotherapy by Claudio Naranjo, documented in his book The Healing Journey. He was awarded patent CA 939266 in 1974. Iboga Powder/Pure Iboga Powder for sale